Dalrada Financial Corporation announced the appointment of Elizabeth Ann Winzeler, Ph.D., a Professor in the Department of Pediatrics at the University of California, San Diego, School of Medicine, as a member of the Dalrada Health advisory board. The group is composed of distinguished life sciences industry leaders whose industry knowledge and guidance are intended to accelerate Dalrada Health’s national healthcare model.
Latest Fintech News: GreenBox POS and Armanino Sign Partnership To Attest to All GreenBox Custodial Accounts in Real-Time.
Dalrada envisions a comprehensive healthcare solution with unique offerings that include physicians and clinicians at treatment clinics, and eventually expanding into telemedicine, engaging Dalrada-owned testing facilities and laboratories, and utilizing Company-specific technologies to facilitate rapid growth of the business. The Company plans on entering the pharmaceutical space with an accelerated strategic plan to leverage its pre-existing capabilities.
Brian Bonar, Dalrada’s Chairman and CEO, states, “Dr. Winzeler’s vast experience in academic and industrial antimicrobial drug discovery will have a positive impact on accelerating Dalrada Health’s initiatives in the pharmaceutical market.”
Dr. Winzeler received a Ph.D. from the Department of Developmental Biology at Stanford University, where she trained under microbiologists and geneticists, before a joint position at the Scripps Research Institute and the Genomics Institute of the Novartis Research Foundation. Her efforts with malaria drug discovery yielded several novel antimalarial chemotypes that are currently in late-stage clinical trials.
Latest Fintech News: Parallel Finance Continues Rapid Product Expansion With Launch of Omni: NFT Money Market
At UCSD, Dr. Winzeler leads a group that uses systematic, data-intensive methods to solve problems at the interface of host-pathogen biology, typically involving large collections of chemical screening data and whole-genome sequencing.
Dr. Winzeler has received many accolades throughout her career, including awards from the Keck Foundation, the Ellison Medical Foundation, and the Bill and Melinda Gates Foundation, where she is currently the Director of the Foundation’s Malaria Drug Accelerator (MalDA). In 2014, Dr. Winzeler was awarded the Bailey-Ashford Medal for distinguished achievements in tropical medicine. Also a fellow of the American Academy of Microbiology, Dr. Winzeler was elected to the National Academy of Medicine this year.
Dalrada Financial Corporation and its subsidiaries provide value by making timely and impactful products and services available within health, technology, and clean energy markets. To learn more about how Dalrada continuously creates innovative solutions to address the complex challenges of today and the future
Latest Fintech News: Designstripe Raises $10MillionFrom Insight Partners and Silicon Valley Bank to Build Smart Design Tools.
[To share your insights with us, please write to sghosh@martechseries.com]
